Evidence map›Paper›PMID 40530005›Full record

ReviewCyborg and bionic systems (Washington, D.C.)2025

Opportunities and Challenges of Brain-on-a-Chip Interfaces.

Wenwei Shao, Weiwei Meng, Jiachen Zuo, Xiaohong Li, Dong Ming

Abstract readReview
In one paragraph

Review in Cyborg and bionic systems (Washington, D.C.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Organoid Brain-Machine-Interface Devices for Central Nervous System Repair.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Wenwei ShaoAcademy of Medical Engineering and Translational Medicine, Tianjin University, Tianjin 300072, China.
Weiwei MengAcademy of Medical Engineering and Translational Medicine, Tianjin University, Tianjin 300072, China.
Jiachen ZuoAcademy of Medical Engineering and Translational Medicine, Tianjin University, Tianjin 300072, China.
Xiaohong LiAcademy of Medical Engineering and Translational Medicine, Tianjin University, Tianjin 300072, China.
Dong MingAcademy of Medical Engineering and Translational Medicine, Tianjin University, Tianjin 300072, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The convergence of life sciences and information technology is driving a new wave of scientific and technological innovation, with brain-on-a-chip interfaces (BoCIs) emerging as a prominent area of focus in the brain-computer interface field. BoCIs aim to create an interactive bridge between lab-grown brains and the external environment, utilizing advanced encoding and decoding technologies alongside electrodes. Unlike classical brain-computer interfaces that rely on human or animal brains, BoCIs employ lab-grown brains, offering greater experimental controllability and scalability. Central to this innovation is the advancement of stem cell and microelectrode array technologies, which facilitate the development of neuro-electrode hybrid structures to ensure effective signal transmission in lab-grown brains. Furthermore, the evolution of BoCI systems depends on a range of stimulation strategies and novel decoding algorithms, including artificial-intelligence-driven methods, which has expanded BoCI applications to pattern recognition and robotic control. Biological neural networks inherently grant BoCI systems neuro-inspired computational properties-such as ultralow energy consumption and dynamic plasticity-that surpass those of conventional artificial intelligence. Functionally, BoCIs offer a novel framework for hybrid intelligence, merging the cognitive capabilities of biological systems (e.g., learning and memory) with the computational efficiency of machines. However, critical challenges span 4 domains: optimizing neural maturation and functional regionalization, engineering high-fidelity bioelectronic interfaces for robust signal transduction, enhancing adaptive neuroplasticity mechanisms in lab-grown brains, and achieving biophysically coherent integration with artificial intelligence architectures. Addressing these limitations could offer insights into emergent intelligence while enabling next-generation biocomputing solutions.

Identifiers

PMID40530005
PMCPMC12173028

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.